mesalamine has been researched along with Tuberculosis, Hepatic in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Tuberculosis, Hepatic: Infection of the LIVER with species of MYCOBACTERIUM, most often MYCOBACTERIUM TUBERCULOSIS. It is characterized by localized small tuberculous miliary lesions or tumor-like mass (TUBERCULOMA), and abnormalities in liver function tests.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dussouillez, G | 1 |
| Zayet, S | 1 |
| Kone, D | 1 |
| Royer, PY | 1 |
| Toko-Tchuindzie, L | 1 |
| Ruyer, O | 1 |
| Gendrin, V | 1 |
1 other study available for mesalamine and Tuberculosis, Hepatic
| Article | Year |
|---|---|
[Tuberculous liver abscess, anti-TNF alpha, and immune reconstitution inflammatory syndrome].
Topics: Adalimumab; Adult; Antirheumatic Agents; Antitubercular Agents; Drug Substitution; Drug Therapy, Com | 2020 |